Simplify Asset Management’s Akero Therapeutics AKRO Stock Holding History

Simplify Asset Management’s Portfolio AKRO Stock Details AKRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-145,609	Closed	-$6.91M	–	144
2025 Q3	$6.91M	Hold	145,609	–	–	0.13%	25
2025 Q2	$7.77M	Hold	145,609	–	–	0.39%	14
2025 Q1	$5.89M	Sell	145,609 -119,068	-45%	-$5.05M	0.22%	23
2024 Q4	$7.36M	Sell	264,677 -19,089	-7%	-$578K	0.36%	16
2024 Q3	$8.14M	Buy	283,766 +38,279	+16%	+$998K	0.38%	28
2024 Q2	$5.76M	Sell	245,487 -189	-0.1%	-$4.04K	0.39%	27
2024 Q1	$6.21M	Buy	245,676 +185,899	+311%	+$4.46M	0.37%	25
2023 Q4	$1.4M	Hold	59,777	–	–	0.13%	58
2023 Q3	$3.02M	Hold	59,777	–	–	0.35%	32
2023 Q2	$2.79M	Hold	59,777	–	–	0.37%	35
2023 Q1	$2.29M	Buy	+59,777	New	+$2.66M	0.33%	34

Other funds holding AKRO

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Simplify Asset Management's AKRO Position: Q4 2025 in Review

Simplify Asset Management sold out of Akero Therapeutics (AKRO) in Q4 2025, closing a stake of 145,609 shares — an estimated $6.91M sold.

Simplify Asset Management first reported a position in AKRO in Q1 2023 and held it in 11 quarters. The position peaked at $8.14M in Q3 2024. 2 funds tracked by Wall St. Rank hold AKRO as of Q4 2025.

Simplify Asset Management reported no remaining Akero Therapeutics position as of Q4 2025 after selling out during the quarter.
Simplify Asset Management sold 145,609 Akero Therapeutics shares in Q4 2025, an estimated $6.91M.
Simplify Asset Management first reported a position in Akero Therapeutics in Q1 2023 and held it in 11 quarters.
Simplify Asset Management's Akero Therapeutics position peaked at $8.14M in Q3 2024.
2 funds tracked by Wall St. Rank held Akero Therapeutics as of Q4 2025.

Based on Simplify Asset Management's 13F filing for Q4 2025, filed 9 Feb 2026.